Articles

Performance coaching - the leadership style that time forgot

29th August 2014

Performance coaching - the leadership style that time forgot Nikki Burgess, Maureen Deehan & Allan Mackintosh

Speakers at recent sales force effectiveness (SFE) conferences have highlighted the importance of line managers coaching sales teams in the field and supporting them with personal development. In a market... Read more

Cancer Drugs Fund budget increased – but pharma prices to be challenge…

28th August 2014

Cancer Drugs Fund budget increased – but pharma prices to be challengedAndrew McConaghie

England's Cancer Drugs Fund is to see its annual budget increased by 40 per cent – but 'excessively priced' drugs could be removed from the list if companies refuse to... Read more

The Game Changer – 3D in Healthcare Apps

28th August 2014

The Game Changer – 3D in Healthcare AppsAshish Khera

Are healthcare apps really changing the healthcare landscape? Ashish Khera discusses the trends, the extent to which apps are affecting the industry and the use of 3D in anatomy-related medical... Read more

The case for one global SOP for medical publications

27th August 2014

The case for one global SOP for medical publicationsRussell Traynor

As medical publishing becomes increasingly global, it makes sense to institute one standard operating procedure to maintain consistency in all markets. However, with budget constraints and regional differences, this is... Read more

News

Ice bucket challenge tally nears $100m

29th August 2014

Ice bucket challenge tally nears $100mStaff Reporter

The ALS Ice Bucket Challenge has raised a staggering $94.3 million for the motor neurone disease (MND) charity behind the initiative, but has left it wondering where to spend the... Read more

Amgen submits BLA to FDA for novel cholesterol drug

29th August 2014

Amgen submits BLA to FDA for novel cholesterol drugLinda Banks

Amgen has submitted the first Biologics Licence Application (BLA) to the US FDA for a PCSK9 inhibitor.Its drug evolocumab is for the treatment of high cholesterol and is an investigational... Read more

BMS hep C drug approved in Europe

28th August 2014

BMS hep C drug approved in EuropeStaff reporter

The news in hepatitis C in recent months has all been about Gilead's record-smashing launch of Sovaldi and whether rival AbbVie will be able to close the gap on the... Read more

NICE wants more cost evidence on BI’s diabetes drug

28th August 2014

NICE wants more cost evidence on BI’s diabetes drugLinda Banks

More evidence on the cost-effectiveness of Boehringer Ingelheim's type 2 diabetes drug empagliflozin has been requested by health watchdog NICE in new draft guidance.Empagliflozin (marketed as Jardiance) is one of... Read more

Audio & Video

Patient Opinion Leaders: Andrew Schorr

 

As a cancer survivor and passionate patient advocate, Andrew Schorr typifies the concept of a Patient Opinion Leader (POL). He is a contributor to the... View more

View the recorded webinar - The future o…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

Rare Disease Day tweetchat

 

To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click View more

Is there common ground for engagement be…

Doctors net webinar

 

The growth of online networks for doctors has been accompanied by recognition from the pharmaceutical industry that these digital meeting grounds can be... View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

StemCells turning a corner?

The path seems to be clearing in front of US biotech StemCells as it advances cell-based therapies for blindness... Read more

News

ViiV gets US approval for Atripla rival Triumeq

Armed with FDA approval for its triple HIV drug Triumeq, ViiV Healthcare can now start to challenge rival Gil... Read more

News

Merck collaborates on novel prostate cancer treatments

Merck has signed an agreement with Advaxis to develop cancer immunotherapies for prostate cancer.Read more

News

Cubist files novel antibiotic in Europe

A novel antibiotic combination from US company Cubist has been filed with the European Union regulator the EMA.<... Read more

News

Ebola 2014: lessons for global healthcare

The current Ebola outbreak has brought to the fore the importance of culture in healthcare, particularly in relation... Read more

Articles

Roche to pay $8.3 billion for InterMune

Roche has swooped to acquire InterMune, the US biotech company behind the potential blockbuster treatment pir... Read more

News